Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS)
CNY 15.62
(0.64%)
CNY 15.62
(0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 920.34 Million | 1.49 Billion | 1.82 Billion | 1.36 Billion | 707.07 Million | 54.32 Million |
| Cost of Revenue | 132.75 Million | 176.18 Million | 157.29 Million | 111.82 Million | 48.29 Million | 11.15 Million |
| Gross Profit | 787.59 Million | 1.31 Billion | 1.66 Billion | 1.25 Billion | 658.78 Million | 43.16 Million |
| Operating Expenses | 672.26 Million | 1.16 Billion | 1.2 Billion | 860.83 Million | 446.31 Million | 86.82 Million |
| Selling, General and Administrative Expenses | 351.06 Million | 761.52 Million | 930.86 Million | 731.76 Million | 365.34 Million | 35.27 Million |
| Research and Development Expenses | 340.75 Million | 356.19 Million | 248.21 Million | 88.77 Million | 55.61 Million | 39.14 Million |
| Other Expenses | -111.25 Million | 44.4 Million | 25.74 Million | 40.29 Million | 25.35 Million | -755.81 Thousand |
| Cost and Expenses | 802.7 Million | 1.33 Billion | 1.36 Billion | 972.66 Million | 494.61 Million | 97.98 Million |
| Operating Income | 124.36 Million | 235.44 Million | 478.75 Million | 398 Million | 199.85 Million | -70.57 Million |
| Interest Expense | 7.06 Million | 1.17 Million | 1.06 Million | 1.83 Million | 14.41 Million | 24.92 Million |
| Income Tax Expense | -7.18 Million | -10.59 Million | 31.84 Million | 54.63 Million | 23.25 Million | -49.32 Million |
| Earnings before Tax | 132.15 Million | 238.39 Million | 477.69 Million | 396.45 Million | 200.16 Million | -71.33 Million |
| Net Income | 139.78 Million | 248.99 Million | 445.85 Million | 343.32 Million | 176.94 Million | -22 Million |
| Earnings Per Share Basic | 0.33 | 0.59 | 1.05 | 0.81 | 0.42 | -0.06 |
| Earnings Per Share Diluted | 0.33 | 0.59 | 1.05 | 0.81 | 0.42 | -0.06 |
| Weighted Average Shares Outstanding | 423.59 Million | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million | 361.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 423.59 Million | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million | 361.39 Million |
| Gross Margin | 0.86 | 0.88 | 0.91 | 0.92 | 0.93 | 0.79 |
| EBIT Margin | 0.22 | 0.20 | 0.29 | 0.31 | 0.33 | -0.42 |
| Profit Margin | 0.15 | 0.17 | 0.24 | 0.25 | 0.25 | -0.41 |
| EBITDA | 203.49 Million | 292.68 Million | 519.89 Million | 423.21 Million | 233.09 Million | -24.3 Million |
| Earnings Before Tax Margin | 0.14 | 0.16 | 0.26 | 0.29 | 0.28 | -1.30 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 319.64 Million | 289.59 Million | 241.19 Million | 265.64 Million | 920.34 Million | 208.56 Million |
| Cost of Revenue | 49.22 Million | 53.55 Million | 40.73 Million | 44.39 Million | 164.77 Million | 28.82 Million |
| Gross Profit | 270.41 Million | 236.04 Million | 200.46 Million | 221.24 Million | 755.56 Million | 179.73 Million |
| Operating Expenses | 213.38 Million | 204.51 Million | 180.18 Million | 201.56 Million | 750.2 Million | 189.05 Million |
| Selling, General and Administrative Expenses | 188.5 Million | 99.64 Million | 116.49 Million | 124.27 Million | - | 125.13 Million |
| Research and Development Expenses | 77.24 Million | 82.27 Million | 65.5 Million | 77.5 Million | - | 88.46 Million |
| Other Expenses | -52.36 Million | 569.98 Thousand | 1.81 Million | 210.45 Thousand | -2.3 Million | 2.67 Million |
| Cost and Expenses | 262.6 Million | 258.07 Million | 220.92 Million | 245.95 Million | 914.98 Million | 217.87 Million |
| Operating Income | 179.38 Million | 32.96 Million | 20.27 Million | 19.68 Million | 5.35 Million | 11.16 Million |
| Interest Expense | 2.99 Million | 3.11 Million | 3.87 Million | 1.88 Million | 6.7 Million | 764.74 Thousand |
| Income Tax Expense | 20.15 Million | 16.2 Million | -7.07 Million | 8.36 Million | -7.18 Million | -6.32 Million |
| Earnings before Tax | 178.71 Million | 33.53 Million | 37.8 Million | 58.87 Million | 131.84 Million | 13.83 Million |
| Net Income | 162.13 Million | 18.77 Million | 46.43 Million | 50.84 Million | 139.78 Million | 20.23 Million |
| Earnings Per Share Basic | 0.38 | 0.04 | 0.11 | 0.12 | - | 0.05 |
| Earnings Per Share Diluted | 0.38 | 0.04 | 0.11 | 0.12 | - | 0.05 |
| Weighted Average Shares Outstanding | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million | 423.6 Million |
| Gross Margin | 0.85 | 0.82 | 0.83 | 0.83 | 0.82 | 0.86 |
| EBIT Margin | 0.57 | 0.13 | 0.17 | 0.14 | - | 0.06 |
| Profit Margin | 0.51 | 0.06 | 0.19 | 0.19 | 0.15 | 0.10 |
| EBITDA | 181.71 Million | 38.83 Million | 41.47 Million | 36.29 Million | - | 12.39 Million |
| Earnings Before Tax Margin | 0.56 | 0.11 | 0.08 | 0.07 | 0.01 | 0.05 |
DCRU
VESTF
GLM
NFEI
GWAY
DHBUF